Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)
US6132967A · kind A · utility
2Cited by
3References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 1998 |
| Grant date | Oct 17, 2000 |
| Priority date | — |
| Expiry date | May 1, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3535
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Enzymatic RNA molecules which cleave ICAM-1 mRNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.